Mozart Therapeutics Completes Ph1a Study in Healthy Adults; Data Shows MTX-101 is Well ...
Mozart Therapeutics, the leading developer of CD8 Treg modulators for the treatment of autoimmune disease, today announce the ...
Morningstar7 天
Mozart Therapeutics Completes Ph1a Study in Healthy Adults; Data Shows MTX-101 is Well ...
Mozart plans to present full data from the Phase 1a study at upcoming medical symposia. "We are thrilled that the initial MTX-101 Phase 1 data in healthy adults confirm the mechanistic and safety ...